Nominally fewer patients on long-term patiromer therapy experienced KFRT and discontinued RAAS inhibitors, but these differences did not reach statistical significance.
← all excerpts
Long-term Patiromer Use and Outcomes Among US Veterans With Hyperkalemia and CKD: A Propensity-Matched Cohort Study.
1
—
—